Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 19, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem to Present at ARM's Regen Med Investor Day and BioCentury's Future Leaders in the Biotech Industry Conference

NEW YORK, March 19, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that the Company will present...
March 17, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem Reports Fourth Data Safety Monitoring Board Review of PreSERVE AMI Trial

NEW YORK, March 17, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, today announced that, on March 11, 2014, the...
March 13, 2014 16:29 ET | Source: Lisata Therapeutics

NeoStem Announces 2013 Year End Financial Results and Provides Corporate Update

NEW YORK, March 13, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company") today announced 2013 year end results and provided an update on its business. NeoStem is a leader...
March 10, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem's Subsidiary, Progenitor Cell Therapy (PCT), Announces Bi-Coastal Facility Expansions

NEW YORK, March 10, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, and its subsidiary, Progenitor Cell Therapy,...
March 06, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem and Mass. Eye and Ear/Schepens Eye Research Institute Announce Second Research Collaboration Exploring NeoStem's VSEL(TM) Technology for Retinal Repair

NEW YORK, March 6, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that it has entered into a...
February 27, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem to Present at Multiple March Conferences

NEW YORK, Feb. 27, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that the Company will present...
February 04, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem Expands Treg International Patent Portfolio With Granting of Patent in Japan

NEW YORK, Feb. 4, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, today announced the expansion of intellectual...
February 03, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem to Present at Multiple February Conferences

NEW YORK, Feb. 3, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that the Company and its...
January 28, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem Welcomes David Altarac, M.D., as Vice President, Regulatory Affairs

NEW YORK, Jan. 28, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today the appointment of Dr. David...
January 13, 2014 07:30 ET | Source: Lisata Therapeutics

NeoStem and its Subsidiary, Progenitor Cell Therapy (PCT), to Present at Five Sessions at the 2014 Phacilitate Cell & Gene Therapy Forum

NEW YORK, Jan. 13, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, and its subsidiary, Progenitor Cell Therapy,...